This information is for healthcare professionals, however not intended for UK or Ireland audience.
Are you a healthcare professional (not UK or Ireland)?
The Factor Lounge
This page is intended for healthcare professionals only and includes promotional content.
Prescribing Information and Adverse Events Reporting information can be found at the bottom of the page.
|
A fast paced video series featuring prominent thought leaders in Haemophilia care. These short videos (3-7 minutes) are packed with valuable insights, expert opinions and experience that will help you to stay up-to date with the latest conversations and treatment developments in Haemophilia care. |
Elevated Protection to Preserve Long-Term Joint Health
Professor Robert Klamroth
Director of the Hemophilia Treatment Centre, Vivantes Hospital in Friedrichshain, Berlin, Germany
Hear Professor Robert Klamroth discuss the importance of good joint health for patients with Haemophilia and the need for inpidually tailored prophylactic treatment for preventing bleeds.
Duration: 3 minutes 55 seconds
The Role & Implications of Extravascular Distribution of Factor IX
Professor Mike Laffan
Professor of Thrombosis and Haemostasis. Imperial College, London
Listen to Professor Mike Laffan discuss coagulation factor IX, its extravascular distribution, and its potential importance in the efficacy of prophylactic therapy.
Duration: 3 minutes 33 seconds
Upgrading PwHB from On-Demand to Prophylaxis
Professor Cedric Hermans
Head of Thrombosis and Haemostasis, Saint-Luc Hospital, Brussels, Belgium
Here, Professor Cedric Hermans discusses the need to upgrade on-demand Haemophilia B patients to prophylaxis in order to increase protection and improve treatment outcomes.
Duration: 7 minutes 53 seconds
Benefits of Switching from SHL Factor VIII to EHL Factor VIII
Dr Steve Austin
Consultant Hematologist, South London, United Kingdom
Listen to Dr Steve Austin discuss the benefits of switching patients with haemophilia A from a standard half-life to an extended half-life factor VIII replacement therapy.
Duration: 6 minutes 07 seconds
How and Why I Switched my Patients to EHL Factor VIII Treatment
Professor Cihan Ay
Haematology, Medical University, Vienna, Austria
In this video, Professor Cihan Ay reflects on his
experience of switching his Haemophilia A patients from
standard half-life products to extended half-life products.
Duration: 5 minutes 02 seconds
Experience of Switching from SHL Factor IX to EHL Factor IX
Professor Niamh O’Connell
Director of the National Coagulation Centre, Dublin, Ireland
Here, Professor Niamh O’Connell discusses why people with Haemophilia B should be switched from standard half-life factor IX prophylaxis to extended half-life factor IX prophylaxis.
Duration: 4 minutes 54 seconds
Managing Patients Going Through Surgery with Alprolix
Professor Niamh O’Connell
Director of the National Coagulation Centre, Dublin, Ireland
Listen to Professor Niamh O’Connell discuss
managing surgery in patients with Haemophilia B
using Alprolix.
Duration: 4 minutes 40 seconds
Elevate protection with personalized prophylaxis for PwHA
Dr Maria Elisa Mancuso
Senior Hematology Consultant, Humanitas Research Hospital, Milan, Italy
In this video, Dr Maria Elisa Mancuso, discusses the importance of personalised prophylactic regiments to optimise protection in Haemophilia A.
Duration: 5 minutes 27 seconds
The importance of FVIII replacement therapy
Dr Maria Elisa Mancuso
Senior Hematology Consultant, Humanitas Research Hospital, Milan, Italy
Here, Dr Maria Elisa Mancuso discusses the important role that factor VIII plays in the prophylactic treatment of patients with haemophilia A.
Duration: 5 minutes 47 seconds